Amrita Y. Krishnan, MD, FACP
Director, Multiple Myeloma Program
Associate Director, Medical Education & Training
Hematology & Hematopoietic Cell Transplantation
Member, Hematologic Malignancies Program, Comprehensive Cancer Center
Associate Professor of Hematology/HCT
City of Hope

Amrita Y. Krishnan, MD, FACP has served as the Director of the Multiple Myeloma Program since 2008 at City of Hope in Duarte, California. Currently, she is also the Associate Director of Medical Education and Training in hematology and hematopoietic cell transplantation (HCT), an associate professor of Hematology and HCT, and is a staff physician at City of Hope.

Prior to receiving her medical degree at Albany Medical College, Dr. Krishnan completed her Bachelor of Science degree in Biology and Modern Languages at Union College in Schenectady, New York. She completed her clinical fellowship in Hematology/Oncology at Harvard Medical School, Beth Israel Deaconess Medical Center. In addition, Dr. Krishnan was a clinical fellow in the Bone Marrow Transplantation, Solid Tumor, and Lymphoma Autologous Marrow Program and served as a Research Fellow in the Division of Hematologic Malignancies at the Dana Farber Cancer Institute. She also completed a clinical rotation in Bone Marrow Transplantation at the Fred Hutchinson Cancer Research Center and a clinical fellowship at City of Hope.

Dr. Krishnan is a national chair on several multiple myeloma transplant studies and is actively involved as a Principal Investigator in Phase I trials for relapsed multiple myeloma. She is the current Co-Chair of the Center for International Blood and Marrow Transplant Research (CIBMTR) Plasma Cell Disorders Committee and a former Chair of the ASCO Plasma Cell Lymphoma Committee.

Dr. Krishnan has made great strides in furthering hematology and HCT research. For example, she was instrumental in bringing hematopoietic cell transplants to patients with lymphoma related to HIV.

She has authored many peer-reviewed articles in the field of multiple myeloma and HCT research and is a leading expert on these topics.